Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Muley

Showing results (161-170 of 224) with videos related to

Pageof 23
Sort By:
Molecular Cell|December 11, 2024
Epitranscriptomic rRNA fingerprinting reveals tissue-of-origin and tumor-specific signaturesIvan Milenkovic, Sonia Cruciani, Laia Llovera, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 23, 2020
A continuous responder algorithm to optimize clinical management of small-cell lung cancer with progastrin-releasing peptide as a simple blood testThomas Muley, Xiaotong Zhang, Stefan Holdenrieder, et al.
Cancers|April 16, 2020
Novel Liquid Biomarker Panels for A Very Early Response Capturing of NSCLC Therapies in Advanced StagesFlorian Janke, Farastuk Bozorgmehr, Sabine Wrenger, et al.
Plos One|March 6, 2008
Integration of gene dosage and gene expression in non-small cell lung cancer, identification of HSP90 as potential targetMariëlle I Gallegos Ruiz, Karijn Floor, Paul Roepman, et al.
Cancer Cell|June 10, 2020
Reduction of Liver Metastasis Stiffness Improves Response to Bevacizumab in Metastatic Colorectal CancerYing Shen, Xiaohong Wang, Junyan Lu, et al.
Frontiers in Oncology|July 16, 2021
Therapeutic and Prognostic Implications of Immune-Related Adverse Events in Advanced Non-Small-Cell Lung CancerLea Daniello, Mariam Elshiaty, Farastuk Bozorgmehr, et al.
Cancers|April 29, 2020
Oligoprogressive Non-Small-Cell Lung Cancer under Treatment with PD-(L)1 InhibitorsStephan Rheinheimer, Claus-Peter Heussel, Philipp Mayer, et al.
Plos One|September 27, 2017
CT characteristics in pulmonary adenocarcinoma with epidermal growth factor receptor mutationJing Zhao, Julien Dinkel, Arne Warth, et al.
Cold Spring Harbor Molecular Case Studies|November 23, 2019
Serial liquid biopsies for detection of treatment failure and profiling of resistance mechanisms in <i>KLC1-ALK</i>-rearranged lung cancerSteffen Dietz, Petros Christopoulos, Lisa Gu, et al.
Clinical Proteomics|August 13, 2014
Validation of a blood protein signature for non-small cell lung cancerMichael R Mehan, Stephen A Williams, Jill M Siegfried, et al.
Pageof 23

Showing results (161-170 of 224) with videos related to

Sort By:
Pageof 23
Molecular Cell|December 11, 2024
Epitranscriptomic rRNA fingerprinting reveals tissue-of-origin and tumor-specific signaturesIvan Milenkovic, Sonia Cruciani, Laia Llovera, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 23, 2020
A continuous responder algorithm to optimize clinical management of small-cell lung cancer with progastrin-releasing peptide as a simple blood testThomas Muley, Xiaotong Zhang, Stefan Holdenrieder, et al.
Cancers|April 16, 2020
Novel Liquid Biomarker Panels for A Very Early Response Capturing of NSCLC Therapies in Advanced StagesFlorian Janke, Farastuk Bozorgmehr, Sabine Wrenger, et al.
Plos One|March 6, 2008
Integration of gene dosage and gene expression in non-small cell lung cancer, identification of HSP90 as potential targetMariëlle I Gallegos Ruiz, Karijn Floor, Paul Roepman, et al.
Cancer Cell|June 10, 2020
Reduction of Liver Metastasis Stiffness Improves Response to Bevacizumab in Metastatic Colorectal CancerYing Shen, Xiaohong Wang, Junyan Lu, et al.
Frontiers in Oncology|July 16, 2021
Therapeutic and Prognostic Implications of Immune-Related Adverse Events in Advanced Non-Small-Cell Lung CancerLea Daniello, Mariam Elshiaty, Farastuk Bozorgmehr, et al.
Cancers|April 29, 2020
Oligoprogressive Non-Small-Cell Lung Cancer under Treatment with PD-(L)1 InhibitorsStephan Rheinheimer, Claus-Peter Heussel, Philipp Mayer, et al.
Plos One|September 27, 2017
CT characteristics in pulmonary adenocarcinoma with epidermal growth factor receptor mutationJing Zhao, Julien Dinkel, Arne Warth, et al.
Cold Spring Harbor Molecular Case Studies|November 23, 2019
Serial liquid biopsies for detection of treatment failure and profiling of resistance mechanisms in <i>KLC1-ALK</i>-rearranged lung cancerSteffen Dietz, Petros Christopoulos, Lisa Gu, et al.
Clinical Proteomics|August 13, 2014
Validation of a blood protein signature for non-small cell lung cancerMichael R Mehan, Stephen A Williams, Jill M Siegfried, et al.
Pageof 23